↓ Skip to main content

Cochrane Database of Systematic Reviews

Mifepristone for uterine fibroids

Overview of attention for article published in Cochrane database of systematic reviews, August 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
8 tweeters
facebook
3 Facebook pages
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
186 Mendeley
Title
Mifepristone for uterine fibroids
Published in
Cochrane database of systematic reviews, August 2012
DOI 10.1002/14651858.cd007687.pub2
Pubmed ID
Authors

Mario Tristan, Leonardo J Orozco, Antonia Steed, Anggie Ramirez-Morera, Peter Stone

Abstract

Uterine fibroids are the most common benign uterine tumours present in women of reproductive age. Mifepristone (RU-486) competitively binds and inhibits progesterone receptors. Studies have suggested that fibroid growth depends on the sexual steroids. Mifepristone has been shown to decrease fibroid size. This review summarises the effects of mifepristone treatment on fibroids and the associated adverse effects as described in randomised controlled trials.

Twitter Demographics

The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 186 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
United States 1 <1%
Unknown 184 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 38 20%
Student > Bachelor 26 14%
Researcher 18 10%
Student > Ph. D. Student 18 10%
Student > Postgraduate 14 8%
Other 37 20%
Unknown 35 19%
Readers by discipline Count As %
Medicine and Dentistry 89 48%
Nursing and Health Professions 15 8%
Psychology 10 5%
Pharmacology, Toxicology and Pharmaceutical Science 6 3%
Agricultural and Biological Sciences 5 3%
Other 21 11%
Unknown 40 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 April 2021.
All research outputs
#2,992,166
of 18,905,383 outputs
Outputs from Cochrane database of systematic reviews
#5,568
of 11,887 outputs
Outputs of similar age
#16,851
of 109,281 outputs
Outputs of similar age from Cochrane database of systematic reviews
#39
of 107 outputs
Altmetric has tracked 18,905,383 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,887 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.7. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 109,281 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 107 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.